Overview

Metabolic Balance Study of Apraglutide in Patients With SBS-IF and Colon-in-Continuity

Status:
Recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
The primary objective of the trial is to evaluate the efficacy of apraglutide in increasing intestinal energy absorption in relation to metabolic balance assessments.
Phase:
Phase 2
Details
Lead Sponsor:
VectivBio AG